Prospective observational study of sentinel lymphadenectomy without further axillary dissection in patients with sentinel node-negative breast cancer

Journal of Clinical Oncology

Volumn 18, Issue 13, 2000, Pages 2553-2559

  Giuliano, Armando E ^a   Haigh, Philip I ^a   Brennan, Meghan B ^a   Hansen, Nora M ^a   Kelley, Mark C ^a   Ye, Wei ^a   Glass, Edwin C ^a   Turner, Roderick R ^a  

^a SAINT JOHN'S HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; DISEASE ASSOCIATION; FEMALE; HUMAN; LYMPH NODE METASTASIS; LYMPHADENECTOMY; LYMPHADENOPATHY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

EID: 0033933807     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2000.18.13.2553     Document Type: Article

References (35)

1. Carter CL, Allen C, Henson DE: Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer 63:181-187, 1989
2. Fisher ER, Sass R, Fisher B: Pathologic findings from the National Surgical Adjuvant Project for Breast Cancers (protocol no. 4). Cancer 53:712-723, 1984
3. Lin PP, Allison DC, Wainstock J, et al: Impact of axillary lymph node dissection on the therapy of breast cancer patients. J Clin Oncol 11:1536-1544, 1993
4. National Institutes of Health: NIH consensus conference on the treatment of early-stage breast cancer. JAMA 265:391-395, 1991
5. Ivens D, Hoe AL, Podd TJ, et al: Assessment of arm morbidity from complete axillary dissection. Br J Cancer 66:1368-1373, 1992
6. Kissin MW, Querci della Rovere G, Easton D, et al: Risk of lymphoedema following the treatment of breast cancer. Br J Surg 73:580-584, 1986
7. Cady B, Stone MD, Schuler JG, et al: The new era in breast cancer: Invasion, size, and nodal involvement dramatically decreasing as a result of mammographic screening. Arch Surg 131:301-308, 1996
8. Krag DN, Weaver DL, Alex JC. et al: Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol 2:335-340, 1993
9. Giuliano AE, Kirgan DM, Guenther JM, et al: Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 220:391-401, 1994
10. Giuliano AE, Jones RC, Brennan M, et al: Sentinel lymphadenectomy in breast cancer. J Clin Oncol 15:2345-2350, 1997
11. Albertini JJ, Lyman GH, Cox C, et al: Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA 276:1818-1822, 1996
12. O'Hea BJ, Hill ADK, El-Shirbiny AM, et al: Sentinel lymph node biopsy in breast cancer: Initial experience at Memorial Sloan-Kettering Cancer Center. J Am Coll Surg 186:423-427, 1998
13. Veronesi U, Paganelli G, Galimberti V, et al: Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet 349:1864-1867, 1997
14. Pijpers R, Meijer S, Hoekstra OS, et al: Impact of lymphoscintigraphy on sentinel node identification with technetium-99m-colloidal albumin in breast cancer. J Nucl Med 38:366-368, 1997
15. Krag D, Weaver D, Ashikaga T, et al: The sentinel node in breast cancer. N Engl J Med 339:941-946, 1998
16. Borgstein PJ, Pijpers R, Comans EF, et al: Sentinel lymph node biopsy in breast cancer: Guidelines and pitfalls of lymphoscintigraphy and gamma probe detection. J Am Coll Surg 186:275-283, 1998
17. De Cicco C, Cremonesi M, Luini A, et al: Lymphoscintigraphy and radioguided biopsy of the sentinel axillary node in breast cancer. J Nucl Med 12:2080-2084, 1998
18. Turner RR, Ollila DW, Krasne DL, et al: Histopathological validation of the sentinel node hypothesis in breast cancer. Ann Surg 226:271-278, 1997
19. Haigh PI, Hansen NM, Qi K, et al: Method of biopsy and excision volume do not affect success rate of subsequent sentinel lymph node dissection in breast cancer. Ann Surg Oncol 7:21-27, 2000
20. Cox CE, Bass SS, Boulware D, et al: Implementation of a new surgical technology: Outcome measures for lymphatic mapping of breast carcinoma. Ann Surg Oncol 6:553-561, 1999
21. Cody HS III, Hill ADK, Tran KN, et al: Credentialing for breast lymphatic mapping: How many cases are enough? Ann Surg 229:723-728, 1999
22. Parmigiani G, Berry DA, Winer EP, et al: Is axillary lymph node dissection indicated for early-stage breast cancer? A decision analysis. J Clin Oncol 17:1465-1473, 1999
23. Haffty BG, Ward B, Pathare P, et al: Reappraisal of the role of axillary lymph node dissection in the conservative treatment of breast cancer. J Clin Oncol 15:691-700, 1997
24. Veronesi U, Paganelli G, Viale G, et al: Sentinel lymph node biopsy and axillary dissection in breast cancer: Results in a large series. J Natl Cancer Inst 91:368-373, 1999
25. Senofsky GM, Moffat Jr FL, Davis K, et al: Total axillary lymphadenectomy in the management of breast cancer. Arch Surg 126:1336-1342, 1991
26. Fisher B, Wolmark N, Bauer M, et al: The accuracy of clinical nodal staging and of limited axillary dissection as a determinant of histologic nodal status in carcinoma of the breast. Surg Gynecol Obstet 152:765-772, 1981
27. Kjaergaard J, Blichert-Toft M, Andersen JA, et al: Probability of false negative nodal staging in conjunction with partial axillary dissection in breast cancer. Br J Surg 72:365-367, 1985
28. Fisher B, Redmond C, Fisher ER, et al: Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. N Engl J Med 312:674-681, 1985
29. Harris JR, Osteen RT: Patients with early breast cancer benefit from effective axillary treatment. Breast Cancer Res Treat 5:17-21, 1985
30. Lythgoe J, Palmer M: Manchester regional breast study: 5 and 10 year results. Br J Surg 69:693-696, 1982
31. Fisher B, Redmond C: Systemic therapy in node-negative patients: Updated findings from NSABP clinical trials - National Surgical Breast and Bowel Project. J Natl Cancer Inst Monogr 11:105-116, 1992
32. Early Breast Cancer Trialists' Collaborative Group: Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy: 133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Lancet 339:71-85, 1992
33. Early Breast Cancer Trialists' Collaborative Group: Tamoxifen for early breast cancer: An overview of the randomised trials. Lancet 351:1451-1467, 1998
34. Ollila DW, Brennan MB, Giuliano AE: Therapeutic effect of sentinel lymphadenectomy in T1 breast cancer. Arch Surg 133:647-651, 1998
35. Hortobagyi GN: Treatment of breast cancer. N Engl J Med 339:974-984, 1998